Bio-Path (NASDAQ:BPTH) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note issued to investors on Saturday. The firm issued a sell rating on the stock. Bio-Path Price Performance Shares of NASDAQ BPTH opened at $0.80 on Friday. Bio-Path has a 12-month low of $0.61 and a 12-month high of $12.37. The […]

Leave a Reply

Your email address will not be published.

Previous post Brookfield Infrastructure Partners (NYSE:BIP) Stock Rating Upgraded by StockNews.com
Next post StockNews.com Begins Coverage on Steel Partners (NYSE:SPLP)